These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Avanzi M; Uber E; Bonfà F Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629 [TBL] [Abstract][Full Text] [Related]
6. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835 [TBL] [Abstract][Full Text] [Related]
7. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration. Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719 [TBL] [Abstract][Full Text] [Related]
8. [L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?]. Wedekind S MMW Fortschr Med; 2005 Jun; 147(22):10. PubMed ID: 15977622 [No Abstract] [Full Text] [Related]
9. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease]. Nakamura Y; Yoshinaga J; Endo S; Hikiji A Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172 [TBL] [Abstract][Full Text] [Related]
10. Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy. Shan DE; Kwan SY; Ho HH; Su MS Mov Disord; 1996 Jul; 11(4):455-7. PubMed ID: 8813234 [No Abstract] [Full Text] [Related]
11. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease. Mihci E; Kardelen F; Dora B; Balkan S Acta Neurol Scand; 2006 May; 113(5):288-93. PubMed ID: 16629763 [TBL] [Abstract][Full Text] [Related]
12. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624 [TBL] [Abstract][Full Text] [Related]
13. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group. Larsen JP; Boas J Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975 [TBL] [Abstract][Full Text] [Related]
15. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
16. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]